Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...
primarily involving adult stem cells. As described below, our two core clinical development programs relate to the treatment ...
Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...
Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived ...
In early November, researchers at Osaka University in Japan published groundbreaking findings in the scientific journal The ...
Hosted on MSN1d
Stem cell treatment helps 3 people see for the first timeNevertheless, Kapil Bharti, a translational stem-cell researcher at the US National Eye Institute, stated, “This is an ...
Aegle Therapeutics says that its mission is to harness the regenerative, immunomodulatory, and anti-inflammatory potential of ...
marks a significant advancement in stem cell therapy and offers hope for a potential cure for type 1 diabetes. While ...
In this webinar, Alex Rimmer, Samuel East, and Catriona Jamieson will discuss how they developed low-cost, animal-free ...
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
Clinicians will soon gain access to trusted education on stem cell-based therapies through a new Continuing Education (CE) course developed by the International Society of Stem Cell Research (ISSCR).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback